Last spring, a rapid polymerase chain reaction (PCR) test for COVID-19 — developed by Northwestern University spinoff company Minute Molecular Diagnostics — received emergency use authorization (EUA) ...
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...
Medical Device Network on MSN
Co-Diagnostics delivers PCR Pro instruments and TB kits to India
The development aligns with recent guidance from the WHO concerning tuberculosis molecular diagnostics in India.
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company has ...
PCR tests, also called molecular tests or nucleic acid tests, are considered the gold standard in detecting the presence of SARS-CoV-2, the virus that gives rise to COVID-19. However, they can take a ...
EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
PCR-based bacterial and fungal detection helps scientists efficiently analyze the sterility of their cell cultures, improving Mycoplasma testing and beyond. Scientists turn to PCR-based methods that ...
Ducharme is a contributor to TIME. A medical worker performs a COVID-19 test at a screening center in Saint-Denis, France, on Nov. 4, 2020. Ducharme is a contributor to TIME. If you had COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results